Health Care: Drugs

Enzon Pharmaceuticals Inc (ENZN: NASDAQ)

$1.33 0.07 | 5.56%
05/27/15 - 10:16 AM ET
Company Profile
Price and Volume
Recent Price 1.26
52 Week High 1.88
52 Week Low 0.85
Avg. Daily Vol. (Mil) 2.79
Beta (3 year) 2.21
Share Related Items
Mkt Cap (Mil) 55.67
Shares Out (Mil) 44.18
Float (Mil) 38.22
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 16.00
Financial Strength
Quick Ratio 49.10
Current Ratio 49.80
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 2.00
Price/Sales 2.03
Price/Book 1.51
Price/Cash Flow 2.00
Per Share Data
Earnings 0.62
Sales 0.62
Book Value 0.83
Cash Flow 0.62
Business Summary
Enzon Pharmaceuticals Inc is related to sales of drugs by various companies. It generates revenues from the sales of products namely, PegIntron, Sylatron, Macugen and CIMZIA.
General Information
20 Kingsbridge Road
Piscataway, NJ 08854
www.enzon.com
Industry : Drugs
Sector: Health Care
Employees: 1
CEO: Mr. George W. Hebard, II
Short Interest
Current Month (Mil) 2.82
Previous Month (Mil) 0.06
Short Interest Ratio (Days) 0.50
Management Effectiveness
Return on Equity 74.60
Return on Assets 72.60
Return on Investments 74.60
Profitability
Gross Margin n.a.
EBIT Margin 90.90
Profit Margin 0.00

Portfolios with ENZN

Latest ENZN Headlines from TheStreet

More Financial News for ENZN

Press Releases for ENZN

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter